Inactive Instrument

Analyst Reco. Standard BioTools Inc.

Equities

Jefferies Downgrades SomaLogic to Hold From Buy, Adjusts Price Target to $2.30 From $3.50	23-10-05	MT
Canaccord Genuity Downgrades SomaLogic to Hold From Buy, Cuts Price Target to $2.50 From $5	23-09-25	MT
Canaccord Genuity Adjusts Price Target on SomaLogic to $5 From $6, Maintains Buy Rating	23-03-29	MT
Stifel Nicolaus Adjusts SomaLogic Price Target to $8 From $12, Maintains Buy Rating	22-08-16	MT
Cowen Adjusts SomaLogic's Price Target to $9 From $11, Keeps Outperform Rating	22-08-16	MT
Cowen Lowers SomaLogic's Price Target to $11 From $14, Maintains Outperform Rating	22-06-23	MT
Canaccord Genuity Lowers SomaLogic's Price Target to $15 From $19, Maintains Buy Rating	22-05-13	MT
Stifel Initiates Coverage on SomaLogic With Buy Rating, $12 Price Target	22-02-01	MT
Canaccord Genuity Starts SomaLogic at Buy With $19 Price Target	21-12-14	MT
Jefferies Starts SomaLogic at Buy With $16 Price Target	21-12-10	MT
Cowen Starts SomaLogic at Outperform With $18 Price Target	21-11-23	MT

No results for this search